GGrantIndex
Sort

11,323 grants matching glioblastoma

Fluorinated macrocyclic peptides as BBB penetrating agent for improved GBM treatment

$599,526
Sean Edward Lawler · Brigham And Women'S Hospital · R01 · FY2020 · CA

STAT3, G6PD and TrxR as underlying mechanisms for antitumor responses tohirsutinolides

$599,483
James K Turkson · Cedars-Sinai Medical Center · R01 · FY2020 · CA

NEW APPROACHES TO BRAIN TUMOR THERAPY CNS CONSORTIUM

$599,409
Johns Hopkins University · U01 · FY2000 · CA

Project 2: Costimulation Pathways in CNS Disease

$599,399
David A. Hafler · Yale University · P01 · FY2017 · AI

Cytochrome C Oxidase: Biomarker In Newly Diagnosed Glioblastoma Multiforme

$599,246
Corinne E. Griguer · University Of Iowa · U01 · FY2018 · NS

Pre-clinical Development of Radiation Sensitizers for Patients with Glioblastoma

$599,228
Kevin Camphausen · Division Of Clinical Sciences - Nci · ZIA · FY2022 · CA

Role of NFKBIA Deficiency in Subverting Neural Progenitor Commitment Toward Gliomagenesis

$599,005
Markus Bredel · University Of Miami School Of Medicine · R01 · FY2025 · NS

Targeting Go and Grow in Glioblastoma

$598,939
Steven S Rosenfeld · Mayo Clinic Jacksonville · R01 · FY2021 · NS

Photothermal Nanoparticles Immune Engineer Tumor-specific T cells for Adoptive Cell Therapy

$598,805
Rohan Fernandes · George Washington University · R01 · FY2024 · CA

Epigenetics and 3D Structure of miR-10b/HoxD Locus in the Brain and Malignant Glioma

$598,782
Anna M. Krichevsky · Brigham And Women'S Hospital · R01 · FY2024 · NS

Advancing Neurosurgical Neuronavigation Using Resting State MRI and Machine Learning

$598,512
Eric Claude Leuthardt · Washington University · R01 · FY2022 · CA

Reorienting the Glioblastoma Microenvironment to Respond to Immunotherapy

$598,289
Mary Helen Barcellos-Hoff · University Of California, San Francisco · R01 · FY2020 · NS

A Phase II Clinical Trial in Newly Diagnosed Glioblastoma Patients Treated with WP1066 and Radiation

$598,126
Amy Beth Heimberger · Northwestern University At Chicago · R01 · FY2025 · CA

A Multipoint Injection Technology for Highly Efficient Convection-Enhanced Delivery of Gene-Based Therapeutics

$598,015
Flavia Vitale · University Of Pennsylvania · R01 · FY2023 · NS

Programming multi-pronged immune response to glioblastoma with IL-13Ra2/TGF-b CAR-T cell therapy.

$597,570
Yvonne Yu-Hsuan Chen · University Of California Los Angeles · R01 · FY2024 · NS

Deciphering the phosphorylation pattern of RNA polymerase II for eukaryotic transcription

$597,526
Yan Jessie Zhang · University Of Texas At Austin · R35 · FY2025 · GM

Deciphering the phosphorylation pattern of RNA polymerase II for eukaryotic transcription

$597,526
Yan Jessie Zhang · University Of Texas At Austin · R35 · FY2024 · GM

Telomerase in Development, Senescence and Neoplasia

$597,518
Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA

Immuno-Cell Therapy for Brain Tumors

$596,913
Xandra Owens Breakefield · Massachusetts General Hospital · R01 · FY2023 · NS

Chemo-radio immunotherapy for pediatric brain tumors

$596,748
David H Munn · Augusta University · R01 · FY2019 · CA

Microenvironmental regulation of glioblastoma radiosensitivity

$596,528
Philip Tofilon · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA

Pre-Clinical Novel Radiosensitizer Evaluation Program for Brain Tumors

$596,490
Jann N Sarkaria · Mayo Clinic Rochester · U01 · FY2018 · CA

Brain Tumor-Penetrating Nanoparticle Delivery with MR-Guided Focused Ultrasound

$595,674
Richard J Price · University Of Virginia · R01 · FY2016 · CA

Laboratory of Genitourinary Cancer Pathogenesis Microscopy Core Facility

$595,655
Ross Lake · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA

STAT5/OLIG2 regulation of GBM therapeutic resistance and recurrence - Resubmit 3.22

$595,640
Nhan L Tran · Mayo Clinic Arizona · R01 · FY2025 · CA